Navigation Links
PointCross Life Sciences' SENDBox and SEND-as-a-Service Prepare Pharma Companies to Comply with the FDA's Upcoming e-Data Submission Mandate
Date:3/11/2013

FOSTER CITY, Calif., March 11, 2013 /PRNewswire/ -- As a result of PDUFA V, the FDA will soon require Biopharma companies to submit their nonclinical study data in standardized electronic formats such as CDISC SEND, the Standard for the Exchange of Nonclinical Data.  This will enable reviewers to analyze all the studies across species in a submission, and to detect weak or important toxicity signals in the data. To help Biopharma companies and their CROs prepare for such regulatory analytics, PointCross Life Sciences announces the immediate availability of its SENDBox™ and SEND-as-a-Service™ offerings.

Biopharma companies and CROs can use the SENDBox™ to assemble data from GLP validated data collection systems, transform them into SEND, and view them before submission.  SENDBox is offered with tools to meet Computer Systems Validation requirements.  It is available as an Enterprise solution behind company firewalls or as a Cloud-hosted service.  SENDBox is based on and compatible with DSIMS®, the engine behind the FDA's SEND-compliant Nonclinical Information Management System (NIMS).  NIMS helps the Agency to better evaluate the safety impact of drugs and improve reviewer efficiency.

SEND-as-a-Service is a Cloud-hosted offering intended for sponsors and CROs who simply wish to outsource the packaging of their disparate datasets, current or past, into SEND.  This service converts their data into SEND ready packages for submission or for analyzing their data in the same way as reviewers.

According to Dr. Shree Nath , VP of PointCross Life Sciences, "The Biopharma industry is moving quickly to become ready for the FDA's upcoming e-data submission directive.  Three top Sponsor companies have selected PointCross to deliver their SEND implementations after a careful evaluation of other providers.  Clients now have the flexibility of deploying the SENDBox solution and assembling SEND datasets themselves, or have our experts do it for them through SEND-as-a-Service.  These new offerings complement our proven DSIMS solution and provide large, mid-size and small Biopharma companies with options that best fit with their business needs."

About PointCross Life Sciences, Inc.

PointCross Life Sciences, Inc. is a global provider of Big Data analytics, data store and translational informatics solutions and services for safety detection across large, disparate, and weakly structured datasets.  Our offerings are used by researchers and reviewers involved with drug development, and are available behind the Enterprise firewall or on the Cloud.  Our clients include several global Biopharma companies as well as the FDA. PointCross Life Sciences is a wholly owned subsidiary of PointCross, Inc.

Contact
Dr. Shree Nath , VP, 
PointCross Life Sciences, Inc. 
1291 E. Hillsdale Blvd., Suite 304
Foster City, CA 94404 
1-866-468-1900 or get_SENDReady@pointcross.com
www.pointcrosslifesciences.com


'/>"/>
SOURCE PointCross Life Sciences, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. For International Life Sciences, Biotech and Pharmaceutical Events, Top Executives Turn to Global Information
2. Sangamo BioSciences Announces Presentation At The Barclays Global Healthcare Conference
3. Particle Sciences and NETZSCH Premier Technologies Enter into Collaboration
4. Dr. Joachim Schorr (PhD) zum Chief Scientific Officer von Caris Life Sciences bestellt
5. Joachim Schorr, PhD, Named Chief Scientific Officer at Caris Life Sciences
6. Presage Biosciences Announces Strategic Research Alliance with Celgene Corporation
7. Heptares to Present at the 6th Annual European Life Sciences CEO Forum (5-6 March)
8. Sangamo BioSciences Announces Presentation At 33rd Annual Cowen And Company Health Care Conference
9. Neurocrine Biosciences To Present At The Cowen And Company 33rd Annual Health Care Conference
10. BioDelivery Sciences to Host Buprenorphine Investor and Analyst Event
11. London Health Sciences Centre Announces Firsts in Treatment Option for Blood Circulation
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... --  Pulmatrix, Inc ., (NASDAQ: PULM ), ... today that it was added to the Russell Microcap ... set of U.S. and global equity indexes on June ... for Pulmatrix," said Chief Executive Officer Robert Clarke ... in developing drugs for crucial unmet medical needs, and ...
(Date:6/23/2016)... June 23, 2016  MedSource announced today that ... e-clinical software solution of choice.  This latest decision ... value to their clients by offering a state-of-the-art ... relationship establishes nowEDC as the EDC platform of ... full-service clients.  "nowEDC has long been a preferred ...
(Date:6/23/2016)... , June 23, 2016 Research ... "Pharmaceutical Excipients Market by Type (Organic Chemical (Sugar, Petrochemical, ... (Oral, Topical, Coating, Parenteral) - Global Forecast to 2021" ... The global pharmaceutical excipients market is ... a CAGR of 6.1% in the forecast period 2016 ...
Breaking Medicine Technology:
(Date:6/25/2016)... Washington, D.C. (PRWEB) , ... June 25, 2016 ... ... will discuss health policy issues and applications at AcademyHealth’s Annual Research Meeting June ... share their work on several important health care topics including advance care planning, ...
(Date:6/25/2016)... Miami, FL (PRWEB) , ... June 25, 2016 , ... The temporary closing of Bruton ... Plant City Observer , brings up a new, often overlooked aspect of head lice: ... The closing for fumigation is not a common occurrence, but a necessary one in the ...
(Date:6/25/2016)... ... ... First Choice Emergency Room , the largest network of independent freestanding emergency ... its new Mesquite-Samuell Farm facility. , “We are pleased to announce Dr. Ogunleye ... M. Muzzarelli, Executive Medical Director of First Choice Emergency Room. , Dr. Ogunleye ...
(Date:6/25/2016)... (PRWEB) , ... June 25, 2016 , ... ... athletes and non-athletes recover from injury. Recently, he has implemented orthobiologic procedures as ... City area —Johnson is one of the first doctors to perform the treatment. ...
(Date:6/25/2016)... ... June 25, 2016 , ... Conventional wisdom preaches the benefits of moderation, ... the latter, setting the bar too high can result in disappointment, perhaps even self-loathing. ... toward their goal. , Research from PsychTests.com reveals that behind the ...
Breaking Medicine News(10 mins):